Showing results (141-150 of 182) with videos related to
Sort By:
Pageof 19
BMC Nephrology|June 3, 2014
Properdin has an ascendancy over factor H regulation in complement-mediated renal tubular damageSeiji Nagamachi, Isao Ohsawa, Hiyori Suzuki, et al.Journal of Clinical Laboratory Analysis|February 9, 2002
Urinary levels of monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8), and renal injuries in patients with type 2 diabetic nephropathyKyouichi Tashiro, Ichiro Koyanagi, Akemi Saitoh, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 12, 2005
Eicosapentaenoic acid ameliorates diabetic nephropathy of type 2 diabetic KKAy/Ta mice: involvement of MCP-1 suppression and decreased ERK1/2 and p38 phosphorylationShinji Hagiwara, Yuichiro Makita, Leyi Gu, et al.Experimental Diabetes Research|August 18, 2012
Effect of exercise on kidney function, oxidative stress, and inflammation in type 2 diabetic KK-A(y) miceYuji Ishikawa, Tomohito Gohda, Mitsuo Tanimoto, et al.Journal of Nephrology|July 5, 2011
Identification of quantitative trait loci for diabetic nephropathy in KK-Ay/Ta miceTatsuya Aoki, Shigeru Kaneko, Mitsuo Tanimoto, et al.Metabolism: Clinical and Experimental|July 16, 2004
Altered mouse cholinephosphotransferase gene expression in kidneys of type 2 diabetic KK/TA mouseTomohito Gohda, Mitsuo Tanimoto, Kenji Shiina, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 9, 2005
A case of renal sarcoidosis with complement activation via the lectin pathwayShinji Hagiwara, Hiroyuki Ohi, Yoshinobu Eishi, et al.Journal of Nephrology|April 23, 2009
Antiproteinuric effect of olmesartan in patients with IgA nephropathyYasuhiko Tomino, Tetsuya Kawamura, Kenjiro Kimura, et al.Journal of the American Society of Nephrology : JASN|September 9, 2008
Toll-like receptor 9 affects severity of IgA nephropathyHitoshi Suzuki, Yusuke Suzuki, Ichiei Narita, et al.Metabolism: Clinical and Experimental|January 17, 2007
Effect of pyridoxamine (K-163), an inhibitor of advanced glycation end products, on type 2 diabetic nephropathy in KK-A(y)/Ta miceMitsuo Tanimoto, Tomohito Gohda, Shigeru Kaneko, et al.Pageof 19